Stem-cell consequences of embryo epigenetic defects

Lancet
Cinzia AllegrucciLorraine Young

Abstract

The genetic code in the DNA of virtually every somatic cell can produce the entire complement of encoded proteins. Acetylation of histones and methylation of histones and DNA cytosine residues are part of the complex epigenetic regulatory process determining lineage-specific gene expression by altering the local structure of chromatin. After fertilisation, sperm DNA exchanges protamines for histones recruited from oocyte cytoplasm, reconfiguring both parental genomes into an epigenetic state conducive to activating the embryonic developmental programme. The identification of epigenetic reprogramming mechanisms is a major interest, rekindled by the ability of at least some somatic cells to acquire totipotency after somatic-cell nuclear transfer. Recently, Woo SukHwang and colleagues (Science 2004; 303: 1669-74) derived a human embryonic stem-cell line from embryo therapeutic cloning. Chad Cowan and colleagues (N Engl JMed 2004; 350: 1353-56) produced 17 new lines from embryos supernumerary to infertility treatments. However, increasing evidence from a range of mammals shows a propensity for epigenetic errors with embryo technologies. If paralleled in human embryos, the effect on tumorigenic and differentiation properties of embr...Continue Reading

References

Oct 10, 2001·Current Biology : CB·D Bourc'hisE Viegas-Péquignot
Jan 11, 2002·Developmental Biology·Fátima SantosWendy Dean
Feb 14, 2002·Differentiation; Research in Biological Diversity·Kunio Shiota, Ryuzo Yanagimachi
Sep 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·David HumpherysRudolf Jaenisch
Sep 19, 2002·Molecular Reproduction and Development·W Shi, T Haaf
Sep 21, 2002·Circulation Research·Chunhui XuMelissa K Carpenter
Dec 25, 2002·Theriogenology·Y M HanK K Lee
Jan 24, 2003·Nature·Gary Felsenfeld, Mark Groudine
Feb 28, 2003·Biology of Reproduction·Young Gie ChungKeith E Latham
Jun 28, 2003·Nature Immunology·K Mark AnselAnjana Rao
Sep 4, 2003·BioTechniques·Bas van Steensel, Steven Henikoff
Oct 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Lidia HernandezColin L Stewart
Dec 5, 2003·Mechanisms of Development·Lorraine E YoungRobert Feil
Jan 28, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Moshe Szyf
Mar 5, 2004·The New England Journal of Medicine·Chad A CowanDouglas A Melton
Apr 6, 2004·Current Biology : CB·Nathalie BeaujeanLorraine Young

❮ Previous
Next ❯

Citations

Dec 17, 2010·Journal of Assisted Reproduction and Genetics·Weiqiang LiuXiaofang Sun
Oct 22, 2008·Nature Cell Biology·Hongyan XingKevin D Sarge
Mar 2, 2005·Nature Reviews. Cancer·J Wolter Oosterhuis, Leendert H J Looijenga
Feb 16, 2006·Reproduction, Fertility, and Development·Jacquetta M Trasler
Nov 2, 2007·Rejuvenation Research·Kaushik Dilip DebSatish Totey
Jul 18, 2008·Human Molecular Genetics·Christopher Thomas Scott, Renee A Reijo Pera
May 12, 2009·Human Reproduction·Weiqiang Liu, Xiaofang Sun
Aug 11, 2006·Genome Research·Marina BibikovaJian-Bing Fan
Aug 11, 2007·Critical Reviews in Oncology/hematology·Caroline AméenPeter Sartipy
Jan 9, 2007·Toxicology·Y R AhujaK Polasa
Nov 6, 2008·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Eva BártováStanislav Kozubek
Apr 29, 2008·Biochemical and Biophysical Research Communications·Jai-Hee MoonSeungkwon You
Dec 20, 2014·International Journal of Molecular Medicine·Quan QiCanquan Zhou
Dec 18, 2004·Critical Reviews in Clinical Laboratory Sciences·Mukesh VermaSudhir Srivastava
Jun 30, 2018·Molecular Reproduction and Development·Flavia R O de Barros, Fabíola F Paula-Lopes
Aug 29, 2006·Human Reproduction Update·C Allegrucci, L E Young

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.